Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Deborah Albright et al.|New England Journal of Medicine|2023Cited by 129
A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiencyStefano Volpi, Rae S. M. Yeung, Maria Pia Cicalese et al.|Journal of Allergy and Clinical Immunology|2019Cited by 119
247 FOXO1 is a master regulator of CAR T memory programmingAlexander Doan, Evan W. Weber, Katherine P. Mueller et al.|Regular and Young Investigator Award Abstracts|2023Cited by 3